Rephonic
Artwork for Cell & Gene: The Podcast

Cell & Gene: The Podcast

Erin Harris
Gene Therapy
Cell and Gene Therapy
Clinical Trials
FDA
Rare Diseases
Solid Tumors
Cell Therapy
Parkinson's Disease
Duchenne Muscular Dystrophy
Gene Editing
Patient Access
Retinitis Pigmentosa
Cancer Treatment
Induced Pluripotent Stem Cells
Regenerative Medicine
Inherited Retinal Disorders
Autoimmune Diseases
CRISPR
Bluerock Therapeutics
Stargardt Disease

Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.

PublishesTwice monthlyEpisodes148Founded5 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for Cell & Gene: The Podcast

Latest Episodes

We love to hear from our listeners. Send us a message.

On episode 139, Host Erin Harris talks to Jonathan Rigby, President and CEO of Sernova (and proposed CEO of BetaNova) and Will Rust, Ph.D., President and CEO of Seraxis (and proposed President a... more

YouTube

We love to hear from our listeners. Send us a message.

In episode 138 of Cell & Gene: The Podcast, EA Weeks, J.D., Ph.D., Counsel at Troutman Pepper Locke talks to Host Erin Harris about the deal terms that matter most in CGT, including IP ownership... more

YouTube

We love to hear from our listeners. Send us a message.

In episode 137 of Cell & Gene: The Podcast, Host Erin Harris talks with Sylke Poehling, Ph.D., SVP and Global Head: Therapeutic Modalities, pRED; Roche Gene Therapy Center of Excellence about ho... more

YouTube

We love to hear from our listeners. Send us a message.

On episode 136 of Cell & Gene: The Podcast, Host Erin Harris welcomes back Dr. Panteli Theocharous, FIBMS, M.S., Ph.D., FRCPath to discuss why autoimmune CAR T is moving rapidly from an emerging... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
ASGCT Podcast Network
ASGCT Podcast NetworkAmerican Society of Gene & Cell Therapy

Recent Guests

EA Weeks
Council at Troutman Pepper Locke; JD, PhD in organic chemistry
Troutman Pepper Locke
Episode: Structuring CGT Deals for the Long Term with Troutman Pepper Locke's EA Weeks, J.D., Ph.D.
Sylke Poehling
SVP and Global Head Therapeutic Modalities at Roche Gene Therapy Center of Excellence
Roche
Episode: Shaping Drug Development by Starting with the Disease with Roche's Sylke Poehling, Ph.D.
Panteli Theocharous
Physician-scientist and cell therapy expert
Clinical development and translational cell therapies
Episode: Why Autoimmune CAR T Needs a New Patient-Centered Playbook with Dr. Panteli Theocharous
Katie Anderson
Chief Editor at Pharmaceutical Online
Episode: Cell & Gene: The Podcast Presents: Better Biopharma’s Editors’ Roundtable — A Midyear Look at the 2026 Life Sciences Industry
Jeff Buguliskis
Deputy Chief Editor at Outsource Pharma
Outsource Pharma
Episode: Cell & Gene: The Podcast Presents: Better Biopharma’s Editors’ Roundtable — A Midyear Look at the 2026 Life Sciences Industry
Ben Comer
Chief Editor at Life Science Leader
Life Science Leader
Episode: Cell & Gene: The Podcast Presents: Better Biopharma’s Editors’ Roundtable — A Midyear Look at the 2026 Life Sciences Industry
Ray Dogum
Chief Editor at Drug Discovery Online
Drug Discovery Online
Episode: Cell & Gene: The Podcast Presents: Better Biopharma’s Editors’ Roundtable — A Midyear Look at the 2026 Life Sciences Industry
Rachel Grabenhofer
Chief Editor at Clinical Supply Leader
Clinical Supply Leader
Episode: Cell & Gene: The Podcast Presents: Better Biopharma’s Editors’ Roundtable — A Midyear Look at the 2026 Life Sciences Industry
Dan Schell
Chief Editor for Clinical Leader
Clinical Leader
Episode: Cell & Gene: The Podcast Presents: Better Biopharma’s Editors’ Roundtable — A Midyear Look at the 2026 Life Sciences Industry

Host

Erin Harris
Host of Cell & Gene: The Podcast and Chief Editor at Cell & Gene

Reviews

4.9 out of 5 stars from 71 ratings
  • Top Notch Podcast

    I’ve learned a great deal listening to this podcast. Erin Harris does a fantastic job of keeping the topics current and the guests she has on are all leaders in the industry.

    Apple Podcasts
    5
    buck025
    United States5 years ago
  • Must listen for anyone in this market

    If you’re interested in what the leaders of the cell therapy and gene therapy market think, this is well worth a subscribe.

    Apple Podcasts
    5
    Derek VS
    United States5 years ago
  • Required Listening

    The cell and gene space is growing and developing quickly. The Cell and Gene Podcast is the best way to keep up with this exciting and quickly developing segment of the pharma industry.

    Apple Podcasts
    5
    MoodyPooty
    United States5 years ago
  • Engaging and dynamic

    Engaging conversations about the fast growing cell and gene space

    Apple Podcasts
    5
    A. Dua
    United States5 years ago
  • Fantastic resource for the CGT sector

    Erin Harris does a great job facilitating concise and straight-to-the-point episodes on an impressive variety of topics and speakers. If you have a stake in the future of cell and gene therapies, then this podcast is a must.

    Apple Podcasts
    5
    Erie Train Fan
    United States5 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Experts value the host's ability to steer focused, concise conversations with industry leaders.
The podcast is a must-listen for anyone involved in CGT and cell therapy, offering a broad perspective across the ecosystem.
Guests consistently bring practical, field-tested insights for CGT development and manufacturing.
Episodes are engaging and dynamic, with a strong emphasis on real-world applications.
Show is a go-to resource for staying current on the fast-changing CGT landscape.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Why Autoimmune CAR T Needs a New Patient-Centered Playbook with Dr. Panteli Theocharous
Q: What advances or shifts look most likely to remove bottlenecks in autoimmune CAR-T access?
Advances in in vivo delivery (e.g., circRNA) and optimized conditioning regimens could reduce reliance on ex vivo manufacturing and complex bridging, thereby shortening timelines and expanding access for patients.
Why Autoimmune CAR T Needs a New Patient-Centered Playbook with Dr. Panteli Theocharous
Q: How should trial design and support services differ in autoimmune CAR-T versus oncology?
Trial design should emphasize clinically meaningful endpoints like durable remission and independence from immunosuppression, and support services must address long-term monitoring and real-world patient burdens, such as employment and caregiving, rather than focusing solely on biomarker changes.
Why Autoimmune CAR T Needs a New Patient-Centered Playbook with Dr. Panteli Theocharous
Q: What are the biggest misunderstandings that cell and gene therapy biotechs still have around that lived patient experience in autoimmune CAR T?
The biggest misunderstanding is applying oncology risk models to autoimmune diseases without adjusting for the different patient journeys and disease trajectories, which leads to misaligned endpoints, consent framing, and expectations.
The Future of In Vivo Gene Editing and Clinical Translation with Precision Biosciences' Cassie Gorsuch, Ph.D.
Q: From your perspective, what technological or biological barriers still stand between current capabilities and routine clinical success in in vivo gene editing?
Cassie explains that while momentum is high and preclinical programs are moving forward, delivery remains a central challenge, especially outside the liver where LNPs are less effective and AAVs have dose and redosing limitations. She emphasizes the importance of platform characteristics, such as Arcus being a single-component editor with small, efficiently packaged nucleases, which helps address both delivery and safety considerations. Selection of accurate preclinical models and translational data interpretation are also key to reducing translational gaps and informing dosing and safety profiles as programs move into clinic.
Advancing CAR T for Drug-Free Remission in Autoimmune Disease with Kyverna Therapeutics’ Dr. Naji Gehchan
Q: From your perspective, what does the outcome of patients discontinuing chronic immunotherapies suggest about the potential for CAR T therapies to shift autoimmune disease treatment away from lifelong disease management?
It demonstrates the core promise of Miv-cel and CAR T in autoimmune disease: durable, drug-free remission that reduces or eliminates the need for chronic therapies, which could redefine treatment goals and patient quality of life.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Cell & Gene: The Podcast

What is Cell & Gene: The Podcast about and what kind of topics does it cover?

The show concentrates on cell and gene therapy and the wider life sciences publishing ecosystem, featuring editors, researchers, and executives discussing the latest in in vivo gene editing, RNA therapies, CAR-T, and regulatory shifts. Episodes commonly cover breakthroughs in delivery platforms, clinical trial design, manufacturing and supply-chain realities, and the evolving regulatory landscape, often tying these threads to practical implications for developers, manufacturers, and investors. A notable strength is bringing cross-industry perspectives from publishers, industry leaders, and academic experts, offering actionable takeaways and forward-looking bets on how the CGT field will evolve in the near term.

Where can I find podcast stats for Cell & Gene: The Podcast?

Rephonic provides a wide range of podcast stats for Cell & Gene: The Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Cell & Gene: The Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Cell & Gene: The Podcast get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Cell & Gene: The Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Cell & Gene: The Podcast?

Rephonic provides comprehensive predictive audience data for Cell & Gene: The Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Cell & Gene: The Podcast have?

To see how many followers or subscribers Cell & Gene: The Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Cell & Gene: The Podcast?

These podcasts share a similar audience with Cell & Gene: The Podcast:

1. BioCentury This Week
2. The Readout Loud
3. Biotech Hangout
4. The Long Run with Luke Timmerman
5. ASGCT Podcast Network

How many episodes of Cell & Gene: The Podcast are there?

Cell & Gene: The Podcast launched 5 years ago and published 148 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Cell & Gene: The Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Cell & Gene: The Podcast?

Rephonic pulls ratings and reviews for Cell & Gene: The Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Cell & Gene: The Podcast?

Rephonic provides full transcripts for episodes of Cell & Gene: The Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Cell & Gene: The Podcast?

Recent guests on Cell & Gene: The Podcast include:

1. EA Weeks
2. Sylke Poehling
3. Panteli Theocharous
4. Katie Anderson
5. Jeff Buguliskis
6. Ben Comer
7. Ray Dogum
8. Rachel Grabenhofer

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days